Retina thickness in clinically affected and unaffected eyes in patients with aquaporin-4 immunoglobulin G antibody seropositive neuromyelitis optica spectrum disorders: a systematic review and meta-analysis
- PMID: 36355186
- DOI: 10.1007/s00415-022-11482-4
Retina thickness in clinically affected and unaffected eyes in patients with aquaporin-4 immunoglobulin G antibody seropositive neuromyelitis optica spectrum disorders: a systematic review and meta-analysis
Abstract
Background and purpose: Retina thickness has been studied in patients with neuromyelitis optica spectrum disorders (NMOSD) without distinguishing serostatus and limited data are available in unaffected eyes. We aimed to investigate retina thickness in eyes of aquaporin-4 immunoglobulin G antibody seropositive (AQP4-IgG+) NMOSD patients with optic neuritis (AQP4-ON) and without (AQP4-NON).
Methods: Eligible studies were identified by searching PubMed and Embase. Mean difference (MD, μm) with corresponding 95% confidence interval (CI) was pooled with random-effect models. The primary measures were average thickness of peripapillar retinal nerve fiber layer (pRNFL) centered on optic disc and the combination of ganglion cell layer and inner plexiform layer (GCIPL) at macula.
Results: We included 21 studies enrolling 787 AQP4-IgG+ NMOSD patients. Compared with healthy control, pRNFL was thinner in eyes of AQP4-ON (- 32.78, 95% CI [- 36.24, - 29.33]) and AQP4-NON (- 2.76, 95% CI [- 3.94, - 1.58]), so was GICPL in AQP4-ON (-21.38, 95% CI [- 24.01, - 18.74]) and AQP4-NON (95% CI - 2.96, [- 3.91, - 2.00]). Compared with multiple sclerosis with ON, AQP4-ON had thinner pRNFL (- 13.56, 95%CI [- 16.51, - 10.60]) and GCIPL (- 9.12, 95% CI [- 11.88, - 6.36]). AQP4-ON and myelin oligodendrocyte glycoprotein antibody-associated demyelination with ON (MOG-ON) had similar pRNFL (0.59, 95% CI [- 6.61, 7.79]) and GCIPL thickness (- 0.55, 95% CI [- 2.92, 1.82]). AQP4-NON had similar pRNFL and GCIPL thickness to MOG-NON and multiple sclerosis without ON.
Conclusions: The average thickness of pRNFL and GICPL decreased both in AQP4-ON and AQP4-NON eyes. AQP4-ON eyes had a similar level of pRNFL and GICPL thinning to MOG-ON eyes, so did AQP4-NON to MOG-NON eyes.
Keywords: Neuromyelitis optica spectrum disorders; Optical coherence tomography; Retina; Serostatus.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD.J Neurol. 2025 Jun 10;272(7):453. doi: 10.1007/s00415-025-13180-3. J Neurol. 2025. PMID: 40495001 Free PMC article.
-
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.J Neuroinflammation. 2016 Nov 1;13(1):282. doi: 10.1186/s12974-016-0720-6. J Neuroinflammation. 2016. PMID: 27802824 Free PMC article.
-
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.Lancet Neurol. 2017 Oct;16(10):797-812. doi: 10.1016/S1474-4422(17)30278-8. Epub 2017 Sep 12. Lancet Neurol. 2017. PMID: 28920886
-
AQP4-IgG and MOG-IgG Related Optic Neuritis-Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis.Front Neurol. 2020 Oct 8;11:540156. doi: 10.3389/fneur.2020.540156. eCollection 2020. Front Neurol. 2020. PMID: 33132999 Free PMC article.
-
The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis.Mult Scler Relat Disord. 2021 Aug;53:103030. doi: 10.1016/j.msard.2021.103030. Epub 2021 May 28. Mult Scler Relat Disord. 2021. PMID: 34118585
Cited by
-
Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study.J Neuroophthalmol. 2025 Jun 1;45(2):164-169. doi: 10.1097/WNO.0000000000002204. Epub 2024 Jul 1. J Neuroophthalmol. 2025. PMID: 38946028
-
[Optic neuritis-Patient sees nothing, doctor sees nothing? : A case of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis].Ophthalmologie. 2025 Sep;122(9):732-737. doi: 10.1007/s00347-025-02236-4. Epub 2025 May 12. Ophthalmologie. 2025. PMID: 40353899 German. No abstract available.
References
-
- Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189 - DOI
-
- Uzawa A, Mori M, Kuwabara S (2014) Neuromyelitis optica: concept, immunology and treatment. J Clin Neurosci 21:12–21 - DOI
-
- Li X, Zhang C, Jia D et al (2021) The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: a systematic review and meta-analysis. Mult Scler Relat Disord 53:103030 - DOI
-
- Oertel FC, Kuchling J, Zimmermann H et al (2017) Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. Neurol Neuroimmunol Neuroinflamm 4:e334 - DOI
-
- Oertel FC, Havla J, Roca-Fernandez A et al (2018) Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. J Neurol Neurosurg Psychiatry 89:1259–1265 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous